Mannitol Dosing for Increased Intracranial Pressure
For increased intracranial pressure, administer mannitol 0.25–1 g/kg IV over 20–30 minutes, with larger doses (0.5 g/kg over 15 minutes) appropriate for acute intracranial hypertensive crisis. 1
Dosing by Age Group
Pediatric Patients
- Standard dose: 0.25–1 g/kg IV over 20–30 minutes 1
- Alternative dosing: 1–2 g/kg or 30–60 g/m² body surface area over 30–60 minutes 2
- Small or debilitated patients: 500 mg/kg 2
- Acute crisis: 0.5 g/kg over 15 minutes for acute intracranial hypertensive crisis 1
Adults
- Standard dose: 0.25–2 g/kg as 15–25% solution over 30–60 minutes 2
- Acute liver failure: 0.5–1 g/kg bolus dose 3
- Traumatic brain injury: Initial 0.5–1 g/kg; maintenance 0.25–1 g/kg every 6 hours 4
Maximum Daily Dose and Monitoring
The maximum 24-hour dose is not explicitly defined in guidelines, but treatment should be guided by serum osmolality monitoring. 3, 4
Critical Safety Parameters:
- Hold mannitol if serum osmolality ≥320 mOsm/kg 3, 4
- Hold if osmolality gap ≥40 4
- Monitor serum osmolality every 6 hours during treatment 4
- Check metabolic profile every 6 hours 4
Administration Guidelines
Preparation and Delivery
- Administer through a filter—do not use solutions containing crystals 1
- Place urinary catheter before mannitol administration 1
- Infusion rate: 15–20 minutes for standard dosing 5
- Concentration: 15–25% solution for adults; 10–20% for most applications 2
Dosing Frequency
The evidence supports every 4-hour dosing for optimal ICP control during acute phase (first 4 days), then adjust based on ICP monitoring 6. However, guidelines typically recommend dosing every 6 hours with monitoring 4.
Mannitol may be repeated once or twice as needed, provided serum osmolality remains <320 mOsm/L 3. The dose-response relationship shows that smaller doses (0.25 g/kg) are as effective as larger doses for acute ICP reduction 7, though larger doses may provide more sustained effect at 5 hours.
Clinical Context and Adjunctive Measures
Mannitol should be used as part of comprehensive ICP management including:
- Head-of-bed elevation to 30 degrees 1, 4
- Sedation/analgesia 1
- Cerebrospinal fluid drainage if available 1
- Consideration of barbiturates or neuromuscular blockade 1
Important Caveats
Prophylactic mannitol is not indicated 3. Use only for documented elevated ICP or clinical signs of herniation (decerebrate posturing, pupillary abnormalities) 3.
Hypertonic saline (3%) may be superior to mannitol in pediatric CNS infections, showing better ICP reduction and outcomes 8. When using hypertonic saline as alternative: initial 5 mL/kg IV over 15 minutes, then 1 mL/kg/hour to target sodium 150–155 mEq/L 4.
Volume compensation is essential as mannitol causes osmotic diuresis 5. Monitor for hyperosmolality, hypernatremia, and volume depletion 1, 2. In patients with renal impairment, dialysis may be needed to remove excess fluid 3.
Contraindications include: well-established anuria, severe pulmonary edema, active intracranial bleeding (except during craniotomy), and severe dehydration 2.